Signaling pathways in rheumatoid arthritis: implications for targeted therapy
Open accessThe DOI matches its Crossref record; 397 of the 397 references it cites were found in a registry or an index.
Abstract
Rheumatoid arthritis (RA) is an incurable systemic autoimmune disease. Disease progression leads to joint deformity and associated loss of function, which significantly impacts the quality of life for sufferers and adds to losses in the labor force. In the past few decades, RA has attracted increased attention from researchers, the abnormal signaling pathways in RA are a very important research field in the diagnosis and treatment of RA, which provides important evidence for understanding this complex disease and developing novel RA-linked intervention targets. The current review intends to provide a comprehensive overview of RA, including a general introduction to the disease, historical events, epidemiology, risk factors, and pathological process, highlight the primary research progress of the disease and various signaling pathways and molecular mechanisms, including genetic factors, epigenetic factors, summarize the most recent developments in identifying novel signaling pathways in RA and new inhibitors for treating RA. therapeutic interventions including approved drugs, clinical drugs, pre-clinical drugs, and cutting-edge therapeutic technologies. These developments will hopefully drive progress in new strategically targeted therapies and hope to provide novel ideas for RA treatment options in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Feng, F.-B., & Qiu, H.-Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.142 · Cited by 211
RetractedLi, G., Zhang, Y., Liu, D., Qian, Y., Zhang, H., Guo, S., Sunagawa, M., Hisamitsu, T., & Liu, Y. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1463-z · Cited by 101
RetractedThe Pathogenesis of Rheumatoid Arthritis
McInnes, I. B., & Schett, G. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1004965 · Cited by 5,514
DNA methylation and its basic function
Moore, L. D., Le, T., & Fan, G. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.112 · Cited by 4,906 · cited 1×
“Abnormal hypermethylation of the CpG islands will prevent transcription factors from binding to the promoter and lead to gene silencing.(307,308) DNA methylation is considered a Fig.”
BackgroundSmolen, J. S., Aletaha, D., & McInnes, I. B. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30173-8 · Cited by 4,870
Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,027
PLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,806
Burden of major musculoskeletal conditions.
(2003) · Europe PMC (PubMed Central) · Cited by 3,521
Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases
Cargnello, M., & Roux, P. P. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00031-10 · Cited by 3,274
Gregersen, P. K., Silver, J., & Winchester, R. J. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780301102 · Cited by 2,599
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
Cytokines in the pathogenesis of rheumatoid arthritis
McInnes, I. B., & Schett, G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2094 · Cited by 2,529
Smolen, J. S., Aletaha, D., Barton, A., Burmester, G. R., Emery, P., Firestein, G. S., Kavanaugh, A., McInnes, I. B., Solomon, D. H., Strand, V., et al. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.1 · Cited by 2,445
Diagnosis and Management of Rheumatoid Arthritis: A Review
Aletaha, D., & Smolen, J. S. (2018) · JAMA · doi:10.1001/jama.2018.13103 · Cited by 2,313
Fibroblast‐like synoviocytes: key effector cells in rheumatoid arthritis
Bartok, B., & Firestein, G. S. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00859.x · Cited by 1,906
Towards a molecular understanding of microRNA-mediated gene silencing
Jonas, S., & Izaurralde, E. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3965 · Cited by 1,872
An overview of microRNAs: Biology, functions, therapeutics, and analysis methods
Saliminejad, K., Khorram Khorshid, H. R., Soleymani Fard, S., & Ghaffari, S. H. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27486 · Cited by 1,872
Nielen, M. M. J., van Schaardenburg, D., Reesink, H. W., van de Stadt, R. J., van der Horst‐Bruinsma, I. E., de Koning, M. H. M. T., Habibuw, M. R., Vandenbroucke, J. P., & Dijkmans, B. A. C. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20018 · Cited by 1,861
The JAK/STAT signaling pathway
Rawlings, J. S., Rosler, K. M., & Harrison, D. A. (2004) · Journal of Cell Science · doi:10.1242/jcs.00963 · Cited by 1,858
Safiri, S., Kolahi, A.-A., Smith, E., Hill, C., Bettampadi, D., Mansournia, M. A., Hoy, D., Ashrafi-Asgarabad, A., Sepidarkish, M., Almasi-Hashiani, A., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216515 · Cited by 1,651
Acetylation and deacetylation of non-histone proteins
Glozak, M. A., Sengupta, N., Zhang, X., & Seto, E. (2005) · Gene · doi:10.1016/j.gene.2005.09.010 · Cited by 1,584 · cited 1×
“Since p53 has been reported as a non-histone protein that can be acetylated by HAT,(457) a drive in research to study other non-histone targets of HDACs and HATs, such as c-MYC, NF-κB, STAT3, α-tubulin has occurred.(458) The non-histone proteins acetylation and deacetylation play roles in all sorts of human diseases,…”
BackgroundWnt signalling regulates adult hippocampal neurogenesis
Lie, D.-C., Colamarino, S. A., Song, H.-J., Désiré, L., Mira, H., Consiglio, A., Lein, E. S., Jessberger, S., Lansford, H., Dearie, A. R., et al. (2005) · Nature · doi:10.1038/nature04108 · Cited by 1,518
Lee, Y. S., & Dutta, A. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092222 · Cited by 1,505
Mammalian MAPK Signal Transduction Pathways Activated by Stress and Inflammation: A 10-Year Update
Kyriakis, J. M., & Avruch, J. (2012) · Physiological Reviews · doi:10.1152/physrev.00028.2011 · Cited by 1,466
Schellekens, G. A., de Jong, B. A., van den Hoogen, F. H., van de Putte, L. B., & van Venrooij, W. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1316 · Cited by 1,450
Matrix Metalloproteinases: Role In Arthritis
Burrage, P. (2006) · Frontiers in Bioscience · doi:10.2741/1817 · Cited by 1,292
Banerjee, S., Biehl, A., Gadina, M., Hasni, S., & Schwartz, D. M. (2017) · Drugs · doi:10.1007/s40265-017-0701-9 · Cited by 1,206
Signaling through the JAK/STAT pathway, recent advances and future challenges
Kisseleva, T., Bhattacharya, S., Braunstein, J., & Schindler, C. W. (2002) · Gene · doi:10.1016/s0378-1119(02)00398-0 · Cited by 1,154
The global burden of rheumatoid arthritis: estimates from the Global Burden of Disease 2010 study
Cross, M., Smith, E., Hoy, D., Carmona, L., Wolfe, F., Vos, T., Williams, B., Gabriel, S., Lassere, M., Johns, N., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204627 · Cited by 1,153
Management of Rheumatoid Arthritis: An Overview
Radu, A.-F., & Bungau, S. G. (2021) · Cells · doi:10.3390/cells10112857 · Cited by 1,089
Novel treatment strategies in rheumatoid arthritis
Burmester, G. R., & Pope, J. E. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31491-5 · Cited by 1,068
The role of JAK/STAT signaling pathway and its inhibitors in diseases.
Xin, P., Xu, X., Deng, C., Liu, S., Wang, Y., Zhou, X., Ma, H., Wei, D., & Sun, S. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106210 · Cited by 1,010
A Brief Review on the Mechanisms of miRNA Regulation
Cai, Y., Yu, X., Hu, S., & Yu, J. (2009) · Genomics, Proteomics & Bioinformatics · doi:10.1016/s1672-0229(08)60044-3 · Cited by 1,001
Raychaudhuri, S., Sandor, C., Stahl, E. A., Freudenberg, J., Lee, H.-S., Jia, X., Alfredsson, L., Padyukov, L., Klareskog, L., Worthington, J., et al. (2012) · Nature Genetics · doi:10.1038/ng.1076 · Cited by 946
Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis
van Vollenhoven, R. F., Fleischmann, R., Cohen, S., Lee, E. B., García Meijide, J. A., Wagner, S., Forejtova, S., Zwillich, S. H., Gruben, D., Koncz, T., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112072 · Cited by 945
Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis
Lin, Y.-J., Anzaghe, M., & Schülke, S. (2020) · Cells · doi:10.3390/cells9040880 · Cited by 932
Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes
Nygaard, G., & Firestein, G. S. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0413-5 · Cited by 928
The etiology of rheumatoid arthritis
Scherer, H. U., Häupl, T., & Burmester, G. R. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102400 · Cited by 881
Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis
Taylor, P. C., Keystone, E. C., van der Heijde, D., Weinblatt, M. E., del Carmen Morales, L., Reyes Gonzaga, J., Yakushin, S., Ishii, T., Emoto, K., Beattie, S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1608345 · Cited by 872
Safiri, S., Kolahi, A. A., Hoy, D., Smith, E., Bettampadi, D., Mansournia, M. A., Almasi-Hashiani, A., Ashrafi-Asgarabad, A., Moradi-Lakeh, M., Qorbani, M., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215920 · Cited by 842
Sparks, J. A. (2019) · Annals of Internal Medicine · doi:10.7326/aitc201901010 · Cited by 811
TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis.
Pettit, A. R., Ji, H., von Stechow, D., Müller, R., Goldring, S. R., Choi, Y., Benoist, C., & Gravallese, E. M. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63016-7 · Cited by 807
The immunology of rheumatoid arthritis
Weyand, C. M., & Goronzy, J. J. (2021) · Nature Immunology · doi:10.1038/s41590-020-00816-x · Cited by 793
The microbiome in infectious disease and inflammation
Honda, K., & Littman, D. R. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074937 · Cited by 791
ACR/EULAR 2010 rheumatoid arthritis classification criteria
Kay, J., & Upchurch, K. S. (2012) · Rheumatology · doi:10.1093/rheumatology/kes279 · Cited by 787
Alamanos, Y., Voulgari, P. V., & Drosos, A. A. (2006) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2006.08.006 · Cited by 782
Dishevelled: The hub of Wnt signaling
Gao, C., & Chen, Y.-G. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2009.11.021 · Cited by 755
The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review
Almutairi, K., Nossent, J., Preen, D., Keen, H., & Inderjeeth, C. (2021) · Rheumatology International · doi:10.1007/s00296-020-04731-0 · Cited by 753
Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis
Chen, Z., Bozec, A., Ramming, A., & Schett, G. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0109-2 · Cited by 719
The PI3K/AKT/mTOR interactive pathway
Ersahin, T., Tuncbag, N., & Cetin-Atalay, R. (2015) · Molecular BioSystems · doi:10.1039/c5mb00101c · Cited by 683
Turesson, C., O'Fallon, W. M., Crowson, C. S., Gabriel, S. E., & Matteson, E. L. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.8.722 · Cited by 672
The PI3K/AKT/mTOR signaling pathway in osteoarthritis: a narrative review
Sun, K., Luo, J., Guo, J., Yao, X., Jing, X., & Guo, F. (2020) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2020.02.027 · Cited by 660
Use of NSAIDs in treating patients with arthritis
Crofford, L. J. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4174 · Cited by 650
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience
Salles, G., Barrett, M., Foà, R., Maurer, J., O’Brien, S., Valente, N., Wenger, M., & Maloney, D. G. (2017) · Advances in Therapy · doi:10.1007/s12325-017-0612-x · Cited by 620
Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications
England, B. R., Thiele, G. M., Anderson, D. R., & Mikuls, T. R. (2018) · BMJ · doi:10.1136/bmj.k1036 · Cited by 609
Targeted protein degradation by PROTACs
Neklesa, T. K., Winkler, J. D., & Crews, C. M. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.027 · Cited by 599 · cited 1×
“PROTAC molecule can bind both the E3ubiquitin ligase and the target protein, thereby causing the target protein ubiquitination and degradation.(466,467) However, PROTAC delivery and bioavailability remain the biggest obstacles to clinic.”
BackgroundOblak, L., van der Zaag, J., Higgins-Chen, A. T., Levine, M. E., & Boks, M. P. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101348 · Cited by 595
Banerjee, S., Biehl, A., Gadina, M., Hasni, S., & Schwartz, D. M. (2017) · Drugs · doi:10.1007/s40265-017-0736-y · Cited by 590
One year in review 2020: pathogenesis of rheumatoid arthritis
Giannini, D., Antonucci, M., Petrelli, F., Bilia, S., Alunno, A., & Puxeddu, I. (2020) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/3uj1ng · Cited by 588
PTEN: Tumor Suppressor and Metabolic Regulator
Chen, C.-Y., Chen, J., He, L., & Stiles, B. L. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00338 · Cited by 583
Post-transcriptional control of miRNA biogenesis
Michlewski, G., & Cáceres, J. F. (2019) · RNA · doi:10.1261/rna.068692.118 · Cited by 563
Keystone, E. C., Genovese, M. C., Klareskog, L., Hsia, E. C., Hall, S. T., Miranda, P. C., Pazdur, J., Bae, S.-C., Palmer, W., Zrubek, J., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.099010 · Cited by 541
Inhibition of DNA Methylation and Reactivation of Silenced Genes by Zebularine
Cheng, J. C., Matsen, C. B., Gonzales, F. A., Ye, W., Greer, S., Marquez, V. E., Jones, P. A., & Selker, E. U. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.5.399 · Cited by 535
The pathogenic role of angiogenesis in rheumatoid arthritis
Elshabrawy, H. A., Chen, Z., Volin, M. V., Ravella, S., Virupannavar, S., & Shahrara, S. (2015) · Angiogenesis · doi:10.1007/s10456-015-9477-2 · Cited by 533
Osteoclasts are essential for TNF-α–mediated joint destruction
Redlich, K., Hayer, S., Ricci, R., David, J.-P., Tohidast-Akrad, M., Kollias, G., Steiner, G., Smolen, J. S., Wagner, E. F., & Schett, G. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15582 · Cited by 531
Notch signalling drives synovial fibroblast identity and arthritis pathology
Wei, K., Korsunsky, I., Marshall, J. L., Gao, A., Watts, G. F. M., Major, T., Croft, A. P., Watts, J., Blazar, P. E., Lange, J. K., et al. (2020) · Nature · doi:10.1038/s41586-020-2222-z · Cited by 528
Rheumatoid Arthritis: Diagnosis and Management
Majithia, V., & Geraci, S. A. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.04.005 · Cited by 522
Rheumatoid arthritis: Extra-articular manifestations and comorbidities
Figus, F. A., Piga, M., Azzolin, I., McConnell, R., & Iagnocco, A. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102776 · Cited by 517
Yang, Y., Guo, L., Wang, Z., Liu, P., Liu, X., Ding, J., & Zhou, W. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120390 · Cited by 503 · cited 1×
“announce the first example of RA treatment using bioactive nanoparticles without any drug loading and highlight the role of folic acid-modified silver nanoparticles (FA-AgNPs) through M1 macrophage apoptosis and M1-to-M2 Macrophage repolarization for targeted RA therapy.(472) A research team from St.”
BackgroundEpigenetics: The link between nature and nurture
Tammen, S. A., Friso, S., & Choi, S.-W. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.07.018 · Cited by 494
van Everdingen, A. A., Jacobs, J. W. G., Siewertsz van Reesema, D. R., & Bijlsma, J. W. J. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-1-200201010-00006 · Cited by 489
Osteoclasts are essential for TNF-α-mediated joint destruction.
Redlich, K., Hayer, S., Ricci, R., David, J.-P., Tohidast-Akrad, M., Kollias, G., Steiner, G., Smolen, J. S., Wagner, E. F., & Schett, G. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215582 · Cited by 474
Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges
Smolen, J. S., & Aletaha, D. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.8 · Cited by 474
Overview of Histone Modification
Zhang, Y., Sun, Z., Jia, J., Du, T., Zhang, N., Tang, Y., Fang, Y., & Fang, D. (2021) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-15-8104-5_1 · Cited by 467
The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting
Malmström, V., Catrina, A. I., & Klareskog, L. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.124 · Cited by 451
Epidemiology and burden of illness of rheumatoid arthritis
Kvien, T. K. (2004) · PharmacoEconomics · doi:10.2165/00019053-200422001-00002 · Cited by 435
The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy
Pavlasova, G., & Mraz, M. (2020) · Haematologica · doi:10.3324/haematol.2019.243543 · Cited by 433
Tocilizumab: A review in rheumatoid arthritis
Scott, L. J. (2017) · Drugs · doi:10.1007/s40265-017-0829-7 · Cited by 419
Understanding the role of cytokines in the pathogenesis of rheumatoid arthritis
Mateen, S., Zafar, A., Moin, S., Khan, A. Q., & Zubair, S. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.02.010 · Cited by 418
Stanczyk, J., Ospelt, C., Karouzakis, E., Filer, A., Raza, K., Kolling, C., Gay, R., Buckley, C. D., Tak, P. P., Gay, S., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30115 · Cited by 407
Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis
Bustamante, M. F., Garcia-Carbonell, R., Whisenant, K. D., & Guma, M. (2017) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1303-3 · Cited by 407
Beyond the joints, the extra-articular manifestations in rheumatoid arthritis
Conforti, A., Di Cola, I., Pavlych, V., Ruscitti, P., Berardicurti, O., Ursini, F., Giacomelli, R., & Cipriani, P. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102735 · Cited by 407
Mor, A., Abramson, S. B., & Pillinger, M. H. (2005) · Clinical Immunology · doi:10.1016/j.clim.2004.12.009 · Cited by 399
An overview of autoantibodies in rheumatoid arthritis
van Delft, M. A. M., & Huizinga, T. W. J. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102392 · Cited by 398
Rheumatoid arthritis progression mediated by activated synovial fibroblasts
Neumann, E., Lefèvre, S., Zimmermann, B., Gay, S., & Müller-Ladner, U. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.07.004 · Cited by 394
The clinical features of rheumatoid arthritis
Grassi, W., De Angelis, R., Lamanna, G., & Cervini, C. (1998) · European Journal of Radiology · doi:10.1016/s0720-048x(98)00038-2 · Cited by 389
Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics
Feldmann, M., & Maini, S. R. N. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00626.x · Cited by 381
“Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
Bousoik, E., & Montazeri Aliabadi, H. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00287 · Cited by 376
Hodge, J. A., Kawabata, T. T., Krishnaswami, S., Clark, J. D., Telliez, J., Dowty, M. E., Menon, S. S., Lamba, M., & Zwillich, S. H. (2016) · PubMed · Cited by 374
AP-1 and NF-kB Regulation in Rheumatoid Arthritis and Murine Collagen-Induced Arthritis
Han, Z., Boyle, D. L., Manning, A. M., & Firestein, G. S. (1998) · Autoimmunity · doi:10.3109/08916939808995367 · Cited by 369
Targeting the PI3K/Akt/mTOR Pathway - Beyond Rapalogs
Markman, B., Dienstmann, R., & Tabernero, J. (2010) · Oncotarget · doi:10.18632/oncotarget.188 · Cited by 355
Ospelt, C., Brentano, F., Rengel, Y., Stanczyk, J., Kolling, C., Tak, P. P., Gay, R. E., Gay, S., & Kyburz, D. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24140 · Cited by 351
Anakinra for Rheumatoid Arthritis: A Systematic Review
MERTENS, M., & SINGH, J. A. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090074 · Cited by 344
Genetics of Rheumatoid Arthritis — A Comprehensive Review
Kurkó, J., Besenyei, T., Laki, J., Glant, T. T., Mikecz, K., & Szekanecz, Z. (2013) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-012-8346-7 · Cited by 343
Nile, C. J., Read, R. C., Akil, M., Duff, G. W., & Wilson, A. G. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23758 · Cited by 338
Smoking and Rheumatoid Arthritis
Chang, K., Yang, S., Kim, S., Han, K., Park, S., & Shin, J. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151222279 · Cited by 337
Wessels, J. A. M., Huizinga, T. W. J., & Guchelaar, H.-J. (2007) · Rheumatology · doi:10.1093/rheumatology/kem279 · Cited by 337
Kadura, S., & Raghu, G. (2021) · European Respiratory Review · doi:10.1183/16000617.0011-2021 · Cited by 328
The role of autoantibodies in the pathophysiology of rheumatoid arthritis
Derksen, V. F. A. M., Huizinga, T. W. J., & van der Woude, D. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0627-z · Cited by 327
Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives
Kitas, G. D., & Gabriel, S. E. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.142133 · Cited by 321
Tyrosine Kinases Btk and Tec Regulate Osteoclast Differentiation by Linking RANK and ITAM Signals
Shinohara, M., Koga, T., Okamoto, K., Sakaguchi, S., Arai, K., Yasuda, H., Takai, T., Kodama, T., Morio, T., Geha, R. S., et al. (2008) · Cell · doi:10.1016/j.cell.2007.12.037 · Cited by 321
NF-κB Signaling Regulates Physiological and Pathological Chondrogenesis
Jimi, E., Huang, F., & Nakatomi, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246275 · Cited by 321
Nociceptive neurons detect cytokines in arthritis
Schaible, H.-G. (2014) · Arthritis Research & Therapy · doi:10.1186/s13075-014-0470-8 · Cited by 319
Sheppard, M., Laskou, F., Stapleton, P. P., Hadavi, S., & Dasgupta, B. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1316909 · Cited by 318
Early Diagnosis and Treatment of Rheumatoid Arthritis
Littlejohn, E. A., & Monrad, S. U. (2018) · Primary Care: Clinics in Office Practice · doi:10.1016/j.pop.2018.02.010 · Cited by 315
DNA hypomethylation in rheumatoid arthritis synovial fibroblasts
Karouzakis, E., Gay, R. E., Michel, B. A., Gay, S., & Neidhart, M. (2009) · Arthritis & Rheumatism · doi:10.1002/art.25018 · Cited by 308
The Lung in Rheumatoid Arthritis: Focus on Interstitial Lung Disease
Spagnolo, P., Lee, J. S., Sverzellati, N., Rossi, G., & Cottin, V. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40574 · Cited by 306
Selected cytokine pathways in rheumatoid arthritis
Noack, M., & Miossec, P. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0619-z · Cited by 303
Tofacitinib: A Review in Rheumatoid Arthritis
Dhillon, S. (2017) · Drugs · doi:10.1007/s40265-017-0835-9 · Cited by 302
The role of the JAK/STAT signal pathway in rheumatoid arthritis
Malemud, C. J. (2018) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x18776224 · Cited by 302
Nonhistone protein acetylation as cancer therapy targets
Singh, B. N., Zhang, G., Hwa, Y. L., Li, J., Dowdy, S. C., & Jiang, S.-W. (2010) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.62 · Cited by 300
Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis
Rubbert-Roth, A., Enejosa, J., Pangan, A. L., Haraoui, B., Rischmueller, M., Khan, N., Zhang, Y., Martin, N., & Xavier, R. M. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2008250 · Cited by 298
RhoA and microtubule dynamics control cell–basement membrane interaction in EMT during gastrulation
Nakaya, Y., Sukowati, E. W., Wu, Y., & Sheng, G. (2008) · Nature Cell Biology · doi:10.1038/ncb1739 · Cited by 294
Immunometabolism in early and late stages of rheumatoid arthritis
Weyand, C. M., & Goronzy, J. J. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.49 · Cited by 291
Sokka, T., Kautiainen, H., Pincus, T., Verstappen, S. M., Aggarwal, A., Alten, R., Andersone, D., Badsha, H., Baecklund, E., Belmonte, M., et al. (2010) · Arthritis Research & Therapy · doi:10.1186/ar2951 · Cited by 284
Padyukov, L., Seielstad, M., Ong, R. T. H., Ding, B., Rönnelid, J., Seddighzadeh, M., Alfredsson, L., & Klareskog, L. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.126821 · Cited by 281
Rheumatoid arthritis: Recent advances on its etiology, role of cytokines and pharmacotherapy
Alam, J., Jantan, I., & Bukhari, S. N. A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.05.055 · Cited by 280
Interleukin-6 in Rheumatoid Arthritis
Pandolfi, F., Franza, L., Carusi, V., Altamura, S., Andriollo, G., & Nucera, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155238 · Cited by 278
Metalloproteases and inhibitors in arthritic diseases
Martel-Pelletier, J., Welsch, D. J., & Pelletier, J.-P. (2001) · Best Practice & Research Clinical Rheumatology · doi:10.1053/berh.2001.0195 · Cited by 270
JAK inhibitors for the treatment of autoimmune and inflammatory diseases
Jamilloux, Y., El Jammal, T., Vuitton, L., Gerfaud-Valentin, M., Kerever, S., & Sève, P. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.102390 · Cited by 264 · cited 1×
“These small molecules help prevent an individual’s immune system from producing certain enzymes that stimulate inflammation.(394) Tofacitinib, a JAK pathway inhibitor developed in 2012, is FDA-approved and marketed under the brand name Xeljanz.”
BackgroundRecent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies
Mueller, A.-L., Payandeh, Z., Mohammadkhani, N., Mubarak, S. M. H., Zakeri, A., Alagheband Bahrami, A., Brockmueller, A., & Shakibaei, M. (2021) · Cells · doi:10.3390/cells10113017 · Cited by 256
Chung, Y.-L., Lee, M.-Y., Wang, A.-J., & Yao, L.-F. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00235-1 · Cited by 253
Damjanov, N., Kauffman, R. S., & Spencer‐Green, G. T. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24485 · Cited by 242
Infliximab-Related Infusion Reactions: Systematic Review
Lichtenstein, L., Ron, Y., Kivity, S., Ben-Horin, S., Israeli, E., Fraser, G. M., Dotan, I., Chowers, Y., Confino-Cohen, R., & Weiss, B. (2015) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjv096 · Cited by 239
Etanercept for the Treatment of Rheumatoid Arthritis
Zhao, S., Mysler, E., & Moots, R. J. (2018) · Immunotherapy · doi:10.2217/imt-2017-0155 · Cited by 236
Role of the JAK–STAT Pathway in Protection Against Myocardial Ischemia/Reperfusion Injury
Bolli, R., Dawn, B., & Xuan, Y.-T. (2003) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(02)00230-x · Cited by 234
Sulfasalazine: A Review of its Use in the Management of Rheumatoid Arthritis
Plosker, G. L., & Croom, K. F. (2005) · Drugs · doi:10.2165/00003495-200565130-00008 · Cited by 226
miRNA Therapeutics: A New Class of Drugs with Potential Therapeutic Applications in the Heart
Bernardo, B. C., Ooi, J. Y., Lin, R. C., & McMullen, J. R. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.107 · Cited by 226
Evolution of decitabine development: Accomplishments, ongoing investigations, and future strategies
Jabbour, E., Issa, J., Garcia‐Manero, G., & Kantarjian, H. (2008) · Cancer · doi:10.1002/cncr.23463 · Cited by 224
Grabiec, A. M., Krausz, S., de Jager, W., Burakowski, T., Groot, D., Sanders, M. E., Prakken, B. J., Maslinski, W., Eldering, E., Tak, P. P., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901467 · Cited by 224
Cytokine receptor signaling pathways
Leonard, W. J., & Lin, J.-X. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.106899 · Cited by 222
Nishida, K., Komiyama, T., Miyazawa, S., Shen, Z., Furumatsu, T., Doi, H., Yoshida, A., Yamana, J., Yamamura, M., Ninomiya, Y., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20709 · Cited by 216
The Jak/STAT pathway: A focus on pain in rheumatoid arthritis
Simon, L. S., Taylor, P. C., Choy, E. H., Sebba, A., Quebe, A., Knopp, K. L., & Porreca, F. (2021) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2020.10.008 · Cited by 214
Diagnosis and management of rheumatoid arthritis.
Wasserman, A. M. (2011) · PubMed · Cited by 213
Angelini, J., Talotta, R., Roncato, R., Fornasier, G., Barbiero, G., Dal Cin, L., Brancati, S., & Scaglione, F. (2020) · Biomolecules · doi:10.3390/biom10071002 · Cited by 213
Grabiec, A. M., Korchynskyi, O., Tak, P. P., & Reedquist, K. A. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.154211 · Cited by 211
JAK/STAT Cytokine Signaling at the Crossroad of NK Cell Development and Maturation
Gotthardt, D., Trifinopoulos, J., Sexl, V., & Putz, E. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02590 · Cited by 211
IL-22 induced cell proliferation is regulated by PI3K/Akt/mTOR signaling cascade
Mitra, A., Raychaudhuri, S. K., & Raychaudhuri, S. P. (2012) · Cytokine · doi:10.1016/j.cyto.2012.06.316 · Cited by 209
Miao, C.-G., Yang, Y.-Y., He, X., Li, X.-F., Huang, C., Huang, Y., Zhang, L., Lv, X.-W., Jin, Y., & Li, J. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.04.002 · Cited by 201
Abatacept: A Review in Rheumatoid Arthritis
Blair, H. A., & Deeks, E. D. (2017) · Drugs · doi:10.1007/s40265-017-0775-4 · Cited by 199
Properties of FDA-approved small molecule protein kinase inhibitors: A 2022 update
Roskoski Jr., R. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2021.106037 · Cited by 198
Fibroblast-like synoviocytes in rheumatoid arthritis: Surface markers and phenotypes
Wu, Z., Ma, D., Yang, H., Gao, J., Zhang, G., Xu, K., & Zhang, L. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107392 · Cited by 192
Lai, S. Y., & Johnson, F. M. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.04.001 · Cited by 190
miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis
Fulci, V., Scappucci, G., Sebastiani, G. D., Giannitti, C., Franceschini, D., Meloni, F., Colombo, T., Citarella, F., Barnaba, V., Minisola, G., et al. (2010) · Human Immunology · doi:10.1016/j.humimm.2009.11.008 · Cited by 190
Dendritic cells, T cells and their interaction in rheumatoid arthritis
Wehr, P., Purvis, H., Law, S.-C., & Thomas, R. (2019) · Clinical and Experimental Immunology · doi:10.1111/cei.13256 · Cited by 189
Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis
Zhao, X., Okeke, N. L., Sharpe, O., Batliwalla, F. M., Lee, A. T., Ho, P. P., Tomooka, B. H., Gregersen, P. K., & Robinson, W. H. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2478 · Cited by 182
TLR2 Expression Is Regulated by MicroRNA miR-19 in Rheumatoid Fibroblast-like Synoviocytes
Philippe, L., Alsaleh, G., Suffert, G., Meyer, A., Georgel, P., Sibilia, J., Wachsmann, D., & Pfeffer, S. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102348 · Cited by 177
A miR-19 regulon that controls NF-κB signaling
Gantier, M. P., Stunden, H. J., McCoy, C. E., Behlke, M. A., Wang, D., Kaparakis-Liaskos, M., Sarvestani, S. T., Yang, Y. H., Xu, D., Corr, S. C., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks521 · Cited by 176
Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease
Roodenrijs, N. M. T., van der Goes, M. C., Welsing, P. M. J., Tekstra, J., Lafeber, F. P. J. G., Jacobs, J. W. G., & van Laar, J. M. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa860 · Cited by 176
The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review
Liang, C., Tian, D., Ren, X., Ding, S., Jia, M., Xin, M., & Thareja, S. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.03.062 · Cited by 175
Mu, N., Gu, J., Huang, T., Zhang, C., Shu, Z., Li, M., Hao, Q., Li, W., Zhang, W., Zhao, J.-K., et al. (2016) · Scientific Reports · doi:10.1038/srep20059 · Cited by 173
Self-citationWysocki, T., Olesińska, M., & Paradowska‐Gorycka, A. (2020) · Cells · doi:10.3390/cells9051127 · Cited by 172
PROTACs to address the challenges facing small molecule inhibitors
Martín-Acosta, P., & Xiao, X. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112993 · Cited by 172
Niederer, F., Ospelt, C., Brentano, F., Hottiger, M. O., Gay, R. E., Gay, S., Detmar, M., & Kyburz, D. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.148957 · Cited by 171
Shi, J. G., Chen, X., McGee, R. F., Landman, R. R., Emm, T., Lo, Y., Scherle, P. A., Punwani, N. G., Williams, W. V., & Yeleswaram, S. (2011) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010389469 · Cited by 168
Osteoporosis in Rheumatic Diseases
Adami, G., Fassio, A., Rossini, M., Caimmi, C., Giollo, A., Orsolini, G., Viapiana, O., & Gatti, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235867 · Cited by 168
Functional TLRs and NODs in Human Gingival Fibroblasts
Uehara, A., & Takada, H. (2007) · Journal of Dental Research · doi:10.1177/154405910708600310 · Cited by 167
Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies
Shi, J., van Veelen, P. A., Mähler, M., Janssen, G. M. C., Drijfhout, J. W., Huizinga, T. W. J., Toes, R. E. M., & Trouw, L. A. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.10.008 · Cited by 166
Castro-Villegas, C., Pérez-Sánchez, C., Escudero, A., Filipescu, I., Verdu, M., Ruiz-Limón, P., Aguirre, M. A., Jiménez-Gomez, Y., Font, P., Rodriguez-Ariza, A., et al. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0555-z · Cited by 166
Epigenetics in rheumatoid arthritis
Klein, K., & Gay, S. (2015) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000128 · Cited by 165
What are the dominant cytokines in early rheumatoid arthritis?
Ridgley, L. A., Anderson, A. E., & Pratt, A. G. (2018) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000470 · Cited by 165
Epigenetic Changes in the Pathogenesis of Rheumatoid Arthritis
Nemtsova, M. V., Zaletaev, D. V., Bure, I. V., Mikhaylenko, D. S., Kuznetsova, E. B., Alekseeva, E. A., Beloukhova, M. I., Deviatkin, A. A., Lukashev, A. N., & Zamyatnin, A. A. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00570 · Cited by 164
Anti-TNF in rheumatoid arthritis: an overview
Radner, H., & Aletaha, D. (2015) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-015-0344-y · Cited by 163
Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?
Coates, L. C., FitzGerald, O., Helliwell, P. S., & Paul, C. (2016) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2016.05.012 · Cited by 161
The pre-clinical phase of rheumatoid arthritis: From risk factors to prevention of arthritis
Petrovská, N., Prajzlerová, K., Vencovský, J., Šenolt, L., & Filková, M. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102797 · Cited by 161
Qin, Y., Cai, M.-L., Jin, H.-Z., Huang, W., Zhu, C., Bozec, A., Huang, J., & Chen, Z. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-222605 · Cited by 161
Targeting the PI3K/AKT/mTOR Pathway in Bladder Cancer
Sathe, A., & Nawroth, R. (2018) · Methods in Molecular Biology · doi:10.1007/978-1-4939-7234-0_23 · Cited by 160
Cribbs, A. P., Kennedy, A., Penn, H., Read, J. E., Amjadi, P., Green, P., Syed, K., Manka, S. W., Brennan, F. M., Gregory, B., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38715 · Cited by 158
Du, H., Zhang, X., Zeng, Y., Huang, X., Chen, H., Wang, S., Wu, J., Li, Q., Zhu, W., Li, H., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01620 · Cited by 157
de Andrés, M. C., Pérez-Pampín, E. M., Calaza, M., Santaclara, F. J., Ortea, I., Gómez-Reino, J. J., & Gonzalez, A. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0748-5 · Cited by 155
Wu, C., Yang, H., Luo, S., & Lai, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020686 · Cited by 155
The role of RANK ligand/osteoprotegerin in rheumatoid arthritis
Geusens, P. (2012) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x12438080 · Cited by 153
Angiogenesis in rheumatoid arthritis
Szekanecz, Z., Besenyei, T., Paragh, G., & Koch, A. E. (2009) · Autoimmunity · doi:10.1080/08916930903143083 · Cited by 152
The epidemiology of established rheumatoid arthritis
Otón, T., & Carmona, L. (2019) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2019.101477 · Cited by 151
The immunobiology of mTOR in autoimmunity
Suto, T., & Karonitsch, T. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102373 · Cited by 149
Non-canonical NF-κB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde?
Noort, A. R., Tak, P. P., & Tas, S. W. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0527-3 · Cited by 146
Gillespie, J., Savic, S., Wong, C., Hempshall, A., Inman, M., Emery, P., Grigg, R., & McDermott, M. F. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33382 · Cited by 146
Notch Signaling Regulates Mouse and Human Th17 Differentiation
Keerthivasan, S., Suleiman, R., Lawlor, R., Roderick, J., Bates, T., Minter, L., Anguita, J., Juncadella, I., Nickoloff, B. J., Le Poole, I. C., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003658 · Cited by 146
Anakinra for the treatment of rheumatoid arthritis: a safety evaluation
Ramírez, J., & Cañete, J. D. D. (2018) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1486819 · Cited by 146
Reynisdottir, G., Olsen, H. H., Joshua, V., Engström, M., Forsslund, H., Karimi, R., Sköld, C. M., Nyrén, S., Eklund, A., Grünewald, J., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-208216 · Cited by 142
Rituximab for rheumatoid arthritis
Lopez-Olivo, M. A., Amezaga, M., McGahan, L., Pollono, E. N., & Suarez-Almazor, M. E. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007356.pub2 · Cited by 141
Bone Loss in Rheumatoid Arthritis: Basic Mechanisms and Clinical Implications
Shim, J., Stavre, Z., & Gravallese, E. M. (2017) · Calcified Tissue International · doi:10.1007/s00223-017-0373-1 · Cited by 140
Synovial activation in rheumatoid arthritis.
Ospelt, C., Neidhart, M., Gay, R., & Gay, S. (2004) · Frontiers in Bioscience · doi:10.2741/1399 · Cited by 138
Intracellular Signaling Pathways in Rheumatoid Arthritis
Malemud, C. J. (2013) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000160 · Cited by 138
Management of fatigue in rheumatoid arthritis
Pope, J. E. (2020) · RMD Open · doi:10.1136/rmdopen-2019-001084 · Cited by 137
BTK Signaling in B Cell Differentiation and Autoimmunity
Corneth, O. B. J., Klein Wolterink, R. G. J., & Hendriks, R. W. (2015) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2015_478 · Cited by 137
IL-4 and IL-12 Regulate Proteoglycan-Induced Arthritis Through Stat-Dependent Mechanisms
Finnegan, A., Grusby, M. J., Kaplan, C. D., O’Neill, S. K., Eibel, H., Koreny, T., Czipri, M., Mikecz, K., & Zhang, J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3345 · Cited by 136
Structural Insights into JAK2 Inhibition by Ruxolitinib, Fedratinib, and Derivatives Thereof
Davis, R. R., Li, B., Yun, S. Y., Chan, A., Nareddy, P. R., Gunawan, S., Ayaz, M., Lawrence, H. R., Reuther, G. W., Lawrence, N. J., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01952 · Cited by 135
Genome-wide Analysis of STAT3-Mediated Transcription during Early Human Th17 Cell Differentiation
Tripathi, S. K., Chen, Z. J., Larjo, A., Kanduri, K., Nousiainen, K., Äijö, T., Ricaño-Ponce, I., Hrdličková, B., Tuomela, S., Laajala, E., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.05.013 · Cited by 134
A comprehensive review of rituximab therapy in rheumatoid arthritis patients
Tavakolpour, S., Alesaeidi, ., Darvishi, M., Ghasemiadl, M., Darabi-Monadi, S., Akhlaghdoust, M., Behjati, S. E., & Jafarieh, A. (2019) · Clinical Rheumatology · doi:10.1007/s10067-019-04699-8 · Cited by 134
Induction of Notch signaling by tumor necrosis factor in rheumatoid synovial fibroblasts
Ando, K., Kanazawa, S., Tetsuka, T., Ohta, S., Jiang, X., Tada, T., Kobayashi, M., Matsui, N., & Okamoto, T. (2003) · Oncogene · doi:10.1038/sj.onc.1206965 · Cited by 133
Stress Relief Techniques: p38 MAPK Determines the Balance of Cell Cycle and Apoptosis Pathways
Whitaker, R. H., & Cook, J. G. (2021) · Biomolecules · doi:10.3390/biom11101444 · Cited by 133
Takeuchi, T., Tanaka, Y., Tanaka, S., Kawakami, A., Iwasaki, M., Katayama, K., Rokuda, M., Izutsu, H., Ushijima, S., Kaneko, Y., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215164 · Cited by 132
Anquetil, F., Clavel, C., Offer, G., Serre, G., & Sebbag, M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402334 · Cited by 131
Rheumatoid arthritis in review: Clinical, anatomical, cellular and molecular points of view
Sharif, Κ., Sharif, A. M., Jumah, F., Oskouian, R. J., & Tubbs, R. S. (2017) · Clinical Anatomy · doi:10.1002/ca.22980 · Cited by 131
Rheumatoid Arthritis: Common Questions About Diagnosis and Management.
Wasserman, A. M. (2018) · PubMed · Cited by 131
GENOVESE, M. C., COHEN, S. B., WOFSY, D., WEINBLATT, M. E., FIRESTEIN, G. S., BRAHN, E., STRAND, V., BAKER, D. G., & TONG, S. E. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.100602 · Cited by 130
Choo, Q., Ho, P. C., Tanaka, Y., & Lin, H. (2010) · Rheumatology · doi:10.1093/rheumatology/keq108 · Cited by 130
Ruschitzka, F., Borer, J. S., Krum, H., Flammer, A. J., Yeomans, N. D., Libby, P., Lüscher, T. F., Solomon, D. H., Husni, M. E., Graham, D. Y., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx508 · Cited by 130
Kwok, S., Cho, M., Park, M., Oh, H.-J., Park, J., Her, Y., Lee, S.-Y., Youn, J., Ju, J. H., Park, K. S., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.33390 · Cited by 129
Cited by
Neutrophil extracellular traps in homeostasis and disease
Wang, H., Kim, S. J., Lei, Y., Wang, S., Wang, H., Huang, H., Zhang, H., & Tsung, A. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01933-x · Cited by 537
Song, Y., Li, J., & Wu, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01952-8 · Cited by 259
Metadata
- Authors
- Ding, Q., Hu, W., Wang, R., Yang, Q., Zhu, M., Li, M., Cai, J., Rose, P., Mao, J., & Zhu, Y. Z.
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2023-02-17
- Volume
- 8
- Issue
- 1
- Pages
- 68-68
- ISSN
- 2059-3635 (ISSN-L)
- OpenAlex
- W4321166025
- Cited by
- 478
- References
- 397
- FWCI
- 82.75
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.